SEARCH

SEARCH BY CITATION

References

  • Fan QW, Muramatsu T, Kadomatsu K (2000). Distinct expression of midkine and pleiotrophin in the spinal cord and placental tissues during early mouse development. Dev Growth Differ 42: 113119.
  • Gomez-Pinilla F, So V, Kesslak JP (1998). Spatial learning and physical activity contribute to the induction of fibroblast growth factor: neural substrates for increased cognition associated with exercise. Neuroscience 85: 5361.
  • Harvey BK, Shen H, Cen GJ, Yoshida Y, Wang Y (2004). Midkine and retinoic acid reduce cerebral infarction induced by middle cerebral artery ligation in rats. Neurosci Lett 369: 138141.
  • Horiba M, Kadomatsu K, Nakamura E, Muramatsu H, Ikematsu S, Sakuma S et al. (2000). Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J Clin Invest 105: 489495.
  • Horiba M, Kadomatsu K, Yasui K, Lee JK, Takenaka H, Sumida A et al. (2006). Midkine plays a protective role against cardiac ischemia/reperfusion injury through a reduction of apoptotic reaction. Circulation 114: 17131720.
  • Ikutomo M, Sakakima H, Matsuda F, Yoshida Y (2013). Midkine-deficient mice delayed degeneration and regeneration after skeletal muscle injury. Acta Histochem pii: S0065-1281(13)00160-8.
  • Inoh K, Muramatsu H, Ochiai K, Torii S, Muramatsu T (2004). Midkine, a heparin-binding cytokine, plays key roles in intraperitoneal adhesions. Biochem Biophys Res Commun 317: 108113.
  • Ishikawa E, Ooboshi H, Kumai Y, Takada J, Nakamura K, Ago T et al. (2009). Midkine gene transfer protects against focal brain ischemia and augments neurogenesis. J Neurol Sci 285: 7884.
  • Kadomatsu K, Tomomura M, Muramatsu T (1988). cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun 151: 13121318.
  • Kadomatsu K, Huang RP, Suganuma T, Murata F, Muramatsu T (1990). A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis. J Cell Biol 110: 607616.
  • Kadomatsu K, Kishida S, Tsubota S (2013). The heparin-binding growth factor midkine: the biological activities and candidate receptors. J Biochem 153: 511521.
  • Kato S, Ishihara K, Shinozawa T, Yamaguchi H, Asano Y, Saito M et al. (1999). Monoclonal antibody to human midkine reveals increased midkine expression in human brain tumors. J Neuropathol Exp Neurol 58: 430441.
  • Kato S, Shinozawa T, Takikawa M, Kato M, Hirano A, Awaya A et al. (2000). Midkine, a new neutrophic factor, is present in glial cytoplasmic inclusions of multiple system atrophy brain. Acta Neuropathol 100: 481489.
  • Kikuchi-Horie K, Kawakami E, Kamata M, Wada M, Nakagawa H, Ohara K et al. (2004). Distinctive expression of midkine in the repair period of rat brain during neurogenesis: immunohistochemical and immunoelectron microscopic observations. J Neurosci Res 75: 678687.
  • Kim MW, Bang MS, Han TR, Ko YJ, Yoon BW, Kim JH et al. (2005). Exercise increased BDNF and trkB in the contralateral hemisphere of the ischemic rat brain. Brain Res 1052: 1621.
  • Kim YB, Ryu JK, Lee HJ, Lim IJ, Park D, Lee MC et al. (2010). Midkine, heparin-binding growth factor, blocks kainic acid-induced seizure and neuronal cell death in mouse hippocampus. BMC Neurosci 11: 42. doi: 10. 1186/1471-2202-11-42
  • Kohno S, Nakagawa K, Hamada K, Harada H, Yamasaki K, Hashimoto K et al. (2004). Midkine promoter-based conditionally replicative adenovirus for malignant glioma therapy. Oncol Rep 12: 7378.
  • Liu X, Mashour GA, Webster HF, Kurtz A (1998). Basic FGF and FGF receptor 1 are expressed in microglia during experimental autoimmune encephalomyelitis: temporally distinct expression of midkine and pleiotrophin. Glia 24: 390397.
  • Maeda N, Ichihara-Tanaka K, Kimura T, Kadomatsu K, Muramatsu T, Noda M (1999). A receptor-like protein-tyrosine phosphatase PTPζ/RPTPβ binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to PTPζ. J Biol Chem 274: 1247412479.
  • Maruyama K, Muramatsu H, Ishiguro N, Muramatsu T (2004). Midkine, a heparin-binding growth factor, is fundamentally involved in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 50: 14201429.
  • Mashour GA, Ratner N, Khan GA, Wang HL, Martuza RL, Kurtz A (2001). The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells. Oncogene 20: 97105.
  • Matsuda F, Sakakima H, Yoshida Y (2011). The effects of early exercise on brain damage and recovery after focal cerebral infarction in rats. Acta Physiol 201: 275287.
  • Matsumoto K, Wanaka A, Takatsuji K, Muramatsu H, Muramatsu T, Tohyama M (1994). Novel family of heparin-binding growth factors, pleiotrophin and midkine, is expressed in the developing rat cerebral cortex. Dev Brain Res 79: 229241.
  • Michikawa M, Kikuchi S, Muramatsu H, Muramatsu T, Kim SU (1993). Retinoic acid responsive gene product, midkine (MK), has neurotrophic functions for mouse spinal cord and dorsal root ganglion neurons in culture. J Neurosci Res 35: 530539.
  • Mishima K, Asai A, Kadomatsu K, Ino Y, Nomura K, Narita Y et al. (1997). Increased expression of midkine during the progression of human astrocytomas. Neurosci Lett 233: 2932.
  • Mochizuki R, Takeda A, Sato N, Kinbara T, Onodera H, Itoyama Y et al. (1998). Induction of midkine expression in reactive astrocytes following rat transient forebrain ischemia. Exp Neurol 149: 7378.
  • Muramatsu H, Muramatsu T (1991). Purification of recombinant midkine and examination of its biological activities: functional comparison of new heparin binding factors. Biochem Biophys Res Commun 177: 652658.
  • Muramatsu H, Shirahama H, Yonezawa S, Maruta H, Muramatsu T (1993). Midkine, a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution. Dev Biol 159: 392402.
  • Muramatsu T (2010). Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases. Proc Jpn Acad Ser B Phys Biol Sci 86: 410425.
  • Muramatsu T (2011). Midkine: a promising molecule for drug development to treat diseases of the central nervous system. Curr Pharm Des 17: 410423.
  • Muramatsu T (2014). Structure and function of midkine as the basis of its pharmacological effects. Br J Pharmacol 171: 814826.
  • Muramoto A, Imagama S, Natori T, Wakao N, Ando K, Tauchi R et al. (2013). Midkine overcomes neurite outgrowth inhibition of chondroitin sulfate proteoglycan without glial activation and promotes functional recovery after spinal cord injury. Neurosci Lett 550: 150155.
  • Nakamura E, Kadomatsu K, Yuasa S, Muramatsu H, Mamiya T, Nabeshima T et al. (1998). Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behaviour. Genes Cells 3: 811822.
  • Neeper SA, Gomez-Pinilla F, Choi J, Cotman CW (1996). Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res 726: 4956.
  • Ochiai K, Muramatsu H, Yamamoto S, Ando H, Muramatsu T (2004). The role of midkine and pleiotrophin in liver regeneration. Liver Int 24: 484491.
  • Sakakima H, Yoshida Y, Kadomatsu K, Yuzawa Y, Matsuo S, Muramatsu T (2004a). Midkine expression in rat spinal motor neurons following sciatic nerve injury. Dev Brain Res 153: 251260.
  • Sakakima H, Yoshida Y, Muramatsu T, Yone K, Goto M, Ijiri K et al. (2004b). Traumatic injury-induced midkine expression in the adult rat spinal cord during the early stage. J Neurotrauma 21: 471477.
  • Sakakima H, Kamizono T, Matsuda F, Izumo K, Ijiri K, Yoshida Y (2006). Midkine and its receptor in regenerating rat skeletal muscle after bupivacaine injection. Acta Histochem 108: 357364.
  • Sakakima H, Yoshida Y, Yamazaki Y, Matsuda F, Ikutomo M, Ijiri K et al. (2009). Disruption of the midkine gene (Mdk) delays degeneration and regeneration in injured peripheral nerve. J Neurosci Res 87: 29082915.
  • Sato W, Kadomatsu K, Yuzawa Y, Muramatsu H, Hotta N, Matsuo S et al. (2001). Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury. J Immunol 167: 34633469.
  • Satoh J, Muramatsu H, Moretto G, Muramatsu T, Chang HJ, Kim ST et al. (1993). Midkine that promotes survival of human neurons is produced by fetal human astrocytes in culture. Brain Res Dev Brain Res 75: 201205.
  • Sekiguchi K, Yokota C, Asashima M, Kaname T, Fan QW, Muramatsu T et al. (1995). Restricted expression of Xenopus midkine gene during early development. J Biochem 118: 94100.
  • Shibata Y, Muramatsu T, Hirai M, Inui T, Kimura T, Saito H et al. (2002). Nuclear targeting by the growth factor midkine. Mol Cell Biol 22: 67886796.
  • Sun XZ, Inouye M, Fukui Y, Hisano S, Sawada K, Muramatsu H et al. (1997). An immunohistochemical study of radial glial cells in the mouse brain prenatally exposed to γ-radiation. J Neuropathol Exp Neurol 56: 13391348.
  • Sun XZ, Takahasi S, Fukui Y, Hisano S, Kubota H, Inouye M (1999). Differential patterns of abnormal neuronal migration in the cerebral cortex of mice prenatally exposed to irradiation. Brain Res Dev Brain Res 114: 99108.
  • Takada J, Ooboshi H, Ago T, Kitazono T, Yao H, Kadomatsu K et al. (2005). Post ischemic gene transfer of midkine, a neurotrophic factor, protects against focal brain ischemia. Gene Ther 12: 487493.
  • Uehara K, Matsubara S, Kadomatsu K, Tsutsui J, Muramatsu T (1992). Genomic structure of human midkine (MK), a retinoic acid-responsive growth/differentiation factor. J Biochem 111: 563567.
  • Unoki K, Ohba N, Arimura H, Muramatsu H, Muramatsu T (1994). Rescue of photoreceptors from the damaging effects of constant light by midkine, a retinoic acid-responsive gene product. Invest Ophthalmol Vis Sci 35: 40634068.
  • Wang JY, Takeuch H, Sonobe Y, Jin S, Mizuno T, Miyakawa S et al. (2008). Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population. Proc Natl Acad Sci U S A 105: 39153920.
  • Wang SY, Yoshida Y, Goto M, Moritoyo T, Izumo S, Sato E et al. (1998). Midkine exists in astrocytes in the early stage of cerebral infarction. Brain Res Dev Brain Res 106: 205209.
  • Weinachter SN, Blavet N, O'Donnell RA, MacKenzie ET, Rapin JR (1990). Models of hypoxia and cerebral ischemia. Pharmacopsychiatry 2: 9497.
  • Yasuhara O, Muramatsu H, Kim SU, Muramatsu T, Maruta H, MgGeer PL (1993). Midkine, a nevel neurotrophic factor, is present in senile plaques of Alzheimer disease. Biochem Biophys Res Commun 192: 13121318.
  • Yokota C, Takahashi S, Eisaki A, Asashima M, Akhter S, Muramatsu T et al. (1998). Midkine counteracts the activin signal in mesoderm induction and promotes neural formation. J Biochem 123: 339346.
  • Yoshida Y, Goto M, Tsutsui J, Ozawa M, Sato E, Osame M et al. (1995). Midkine is present in the early stage of cerebral infarct. Brain Res Dev Brain Res 85: 2530.
  • Yoshida Y, Ikematsu S, Moritoyo T, Goto M, Tsutsui J, Sakuma S et al. (2001). Intraventricular administration of the neurotrophic factor midkine ameliorates hippocampal delayed neuronal death following transient forebrain ischemia in gerbils. Brain Res 894: 4655.
  • Yoshida Y, Ikematsu S, Muramatsu H, Sakakima H, Mizuma N, Matsuda F et al. (2008). Expression of the heparin-binding growth factor midkine in the cerebrospinal fluid of patients with neurological disorders. Intern Med 47: 8389.
  • Zhou H, Muramatsu T, Halfter W, Tsim KWK, Peng HB (1997). A role of midkine in the development of the neuromuscular junction. Mol Cell Neurosci 10: 5670.
  • Zou P, Muramatsu H, Miyata T, Muramatsu T (2006). Midkine, a heparin-binding growth factor, is expressed in neural precursor cells and promotes their growth. J Neurochem 99: 14701479.